The Pharmacy and Poisons Board (PPB) has slashed the period required to evaluate and register new cancer drugs from two years to three months.
Bold Reporting Takes Time, Courage and Investment. Stand With Us.
- Unlimited access to all premium content
- Uninterrupted ad-free browsing experience
- Mobile-optimized reading experience
- Weekly Newsletters
- MPesa, Airtel Money and Cards accepted